BlackRock Fund Advisors - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 29 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$117,000
-8.6%
67,554
+2.6%
0.00%
Q3 2016$128,000
+11.3%
65,846
-0.3%
0.00%
Q2 2016$115,000
+69.1%
66,072
+32.1%
0.00%
Q1 2016$68,000
-25.3%
50,011
-7.3%
0.00%
Q4 2015$91,000
-9.9%
53,975
+3.8%
0.00%
Q3 2015$101,000
-1.0%
52,014
+37.5%
0.00%
Q2 2015$102,00037,8340.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$11,887,0008.85%
Foresite Capital Management IV, LLC 1,787,094$12,939,0002.92%
Copernicus Capital Management, LLC 278,416$2,016,0001.92%
Sio Capital Management, LLC 1,159,236$8,393,0001.66%
ACUTA CAPITAL PARTNERS, LLC 765,000$5,539,0001.50%
Avoro Capital Advisors LLC 10,300,000$74,572,0001.06%
Boxer Capital, LLC 4,000,000$28,960,0001.00%
Vivo Capital, LLC 2,089,356$15,127,0000.87%
EAM Global Investors LLC 284,534$2,060,0000.76%
Versant Venture Management, LLC 543,753$3,937,0000.72%
View complete list of CYMABAY THERAPEUTICS INC shareholders